Analysts predict that Colgate-Palmolive (NYSE:CL) will announce $0.73 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Colgate-Palmolive’s earnings. The lowest EPS estimate is $0.73 and the highest is $0.75. Colgate-Palmolive posted earnings of $0.75 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 2.7%. The firm is expected to report its next earnings results on Friday, January 25th.
On average, analysts expect that Colgate-Palmolive will report full-year earnings of $2.96 per share for the current year, with EPS estimates ranging from $2.95 to $2.98. For the next fiscal year, analysts expect that the business will report earnings of $3.05 per share, with EPS estimates ranging from $2.93 to $3.30. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that cover Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.85 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 earnings per share.
Colgate-Palmolive stock traded down $0.52 during trading hours on Friday, hitting $62.71. 4,072,657 shares of the stock were exchanged, compared to its average volume of 4,488,039. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 64.85. The stock has a market capitalization of $54.84 billion, a price-to-earnings ratio of 21.85, a P/E/G ratio of 3.11 and a beta of 0.76. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $77.91.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Friday, October 19th were paid a $0.42 dividend. The ex-dividend date of this dividend was Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a yield of 2.68%. Colgate-Palmolive’s payout ratio is presently 58.54%.
In other Colgate-Palmolive news, VP Philip G. Shotts sold 462 shares of the stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total value of $30,977.10. Following the sale, the vice president now directly owns 41,250 shares in the company, valued at $2,765,812.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Henning I. Jakobsen sold 1,015 shares of the stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $68,055.75. Following the completion of the sale, the chief financial officer now owns 36,193 shares in the company, valued at $2,426,740.65. The disclosure for this sale can be found here. 1.02% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of CL. Fundsmith Equity Fund L.P. acquired a new stake in Colgate-Palmolive in the second quarter worth $232,451,000. Genesis Asset Managers LLP acquired a new stake in Colgate-Palmolive in the third quarter worth $184,557,000. Charles Schwab Investment Advisory Inc. acquired a new stake in Colgate-Palmolive in the second quarter worth $173,852,000. Bank of New York Mellon Corp raised its holdings in Colgate-Palmolive by 8.6% in the second quarter. Bank of New York Mellon Corp now owns 20,135,385 shares of the company’s stock worth $1,304,974,000 after purchasing an additional 1,596,825 shares during the period. Finally, Flossbach Von Storch AG raised its holdings in Colgate-Palmolive by 162.5% in the second quarter. Flossbach Von Storch AG now owns 1,759,030 shares of the company’s stock worth $114,003,000 after purchasing an additional 1,088,805 shares during the period. Institutional investors own 75.10% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Recommended Story: Earnings Reports
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.